N4 PHARMA PLC — Director's Dealing 2017

Mar 2, 2017

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3484Y

Verona Pharma PLC

02 March 2017

Verona Pharma plc

PDMR Dealing

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Dr. Jan-Anders Karlsson

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Verona Pharma plc

b)

LEI

n/a

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 5 pence each

GB00BYW2KH80

b)

Nature of the transaction

Jan-Anders Karlsson purchased 19,750 Ordinary Shares

c)

Price(s) and volume(s)

Price(s)	Volume(s)
149 pence per Ordinary Share	12,000 Ordinary Shares
149 pence per Ordinary Share	7,750 Ordinary Shares

d)

Aggregated information

-         Aggregated volume

-         Price

19,750 Ordinary Shares at 149 pence per Ordinary Share

e)

Date of the transaction

12,000 Ordinary Shares on 28 February 2017 and 7,750 Ordinary Shares on 1 March 2017

f)

Place of the transaction

London Stock Exchange, AIM

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHEANDAEDFXEEF